News >

Targeted Agents Transforming AML Paradigm

Nichole Tucker
Published: Wednesday, Jul 24, 2019

Elias Jabbour, MD

Elias Jabbour, MD

The FDA approval of multiple targeted agents in recent years is transforming the treatment landscape in acute myeloid leukemia (AML), explained Elias Jabbour, MD, professor of medicine, Department of Leukemia, MD Anderson Cancer Center.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication